PDT Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.45M Sell
11,600
-3,500
-23% -$754K 0.15% 215
2025
Q4
$3.1M Buy
+15,100
New +$2.84M 0.2% 183
2025
Q3
Sell
-4,452
Closed -$748K 597
2025
Q2
$748K Sell
4,452
-34,140
-88% -$5.07M 0.04% 469
2025
Q1
$5.32M Sell
38,592
-2,608
-6% -$332K 0.38% 59
2024
Q4
$4.87M Hold
41,200
0.43% 33
2024
Q3
$4.55M Sell
41,200
-5,600
-12% -$586K 0.4% 38
2024
Q2
$4.6M Buy
46,800
+28,889
+161% +$2.94M 0.44% 40
2024
Q1
$2M Buy
+17,911
New +$1.93M 0.19% 193
2015
Q4
Sell
-61,451
Closed -$4.72M 474
2015
Q3
$4.72M Buy
61,451
+41,351
+206% +$3.46M 0.11% 238
2015
Q2
$1.68M Buy
+20,100
New +$1.77M 0.04% 501
2014
Q3
Sell
-7,816
Closed -$536K 1324
2014
Q2
$536K Buy
+7,816
New +$532K 0.01% 963
2013
Q3
Sell
-169,387
Closed -$8M 1506
2013
Q2
$8M Buy
+169,387
New +$7.74M 0.2% 123

Other funds holding CAH

PDT Partners's CAH Position: Q1 2026 in Review

PDT Partners reduced its Cardinal Health (CAH) stake by 23% in Q1 2026, selling an estimated $754K and leaving 11,600 shares worth $2.45M. The position accounts for 0.15% of the portfolio, ranked #215.

PDT Partners first reported a position in CAH in Q2 2013 and has held it in 12 quarters since. The position peaked at $8M in Q2 2013. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • PDT Partners held 11,600 shares of Cardinal Health worth $2.45M as of Q1 2026.
  • PDT Partners sold 3,500 Cardinal Health shares in Q1 2026, an estimated $754K.
  • Cardinal Health made up 0.15% of PDT Partners's portfolio in Q1 2026, its #215 holding.
  • PDT Partners first reported a position in Cardinal Health in Q2 2013 and has held it in 12 quarters since.
  • PDT Partners's Cardinal Health position peaked at $8M in Q2 2013.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.